Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cerebral Glioblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00611728
What this trial is testing

Ph I SU011248 + Irinotecan in Treatment of Pts w MG

Who this might be right for
Glioblastoma
Duke University 25
Not applicableLooking for participantsNCT06146725
What this trial is testing

The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)

Who this might be right for
GlioblastomaGlioblastoma, IDH-wildtypeGlioblastoma Multiforme+2 more
Jasper Gerritsen 564
Early research (Phase 1)Study completedNCT01922076
What this trial is testing

Adavosertib and Local Radiation Therapy in Treating Children With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaDiffuse Intrinsic Pontine Glioma+3 more
National Cancer Institute (NCI) 46
Early research (Phase 1)Study completedNCT00063973
What this trial is testing

Cilengitide in Treating Children With Refractory Primary Brain Tumors

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+23 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT00047294
What this trial is testing

Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00107003
What this trial is testing

GW572016 to Treat Recurrent Malignant Brain Tumors

Who this might be right for
GliomaBrain TumorGlioblastoma Multiforme+3 more
National Cancer Institute (NCI) 9
Not applicableStudy completedNCT01240161
What this trial is testing

Personalized Translational Platform for Biomarker Discovery in Brain Tumors

Who this might be right for
High Grade Glioma
Marcelo F. Di Carli, MD, FACC 37
Testing effectiveness (Phase 2)Study completedNCT00379080
What this trial is testing

Tandutinib in Treating Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Adult Brain TumorAdult Giant Cell GlioblastomaAdult Glioblastoma+2 more
National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Early research (Phase 1)UnknownNCT00003842
What this trial is testing

IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma

Who this might be right for
Brain and Central Nervous System Tumors
Barrett Cancer Center 30
Early research (Phase 1)Study completedNCT00005796
What this trial is testing

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ
Indiana University 10
Early research (Phase 1)Study completedNCT00390403
What this trial is testing

Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Testing effectiveness (Phase 2)Ended earlyNCT03973918
What this trial is testing

Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG

Who this might be right for
High Grade GliomaBRAF V600EBRAF V600K+4 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 5
Not applicableEnded earlyNCT02039778
What this trial is testing

Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma

Who this might be right for
GlioblastomaMalignant GliomaBrain Tumors+1 more
Beth Israel Medical Center 4
Very early researchStudy completedNCT01770626
What this trial is testing

A Pilot Study to Determine Nutrition Status in Glioblastoma Multiforme Patients

Who this might be right for
Brain Cancer
University of Alabama at Birmingham 40
Large-scale testing (Phase 3)Study completedNCT00369785
What this trial is testing

Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors

Who this might be right for
Brain TumorsMetastatic Disease
Wake Forest University Health Sciences 198
Testing effectiveness (Phase 2)Study completedNCT00012038
What this trial is testing

Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Not applicableUnknownNCT03896958
What this trial is testing

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)

Who this might be right for
Cancer, All TypesCancer of LiverCancer of Stomach+42 more
SpeciCare 1,000
Not applicableActive Not RecruitingNCT03115333
What this trial is testing

DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma

Who this might be right for
GliosarcomaRecurrent Glioblastoma
ECOG-ACRIN Cancer Research Group 146
Testing effectiveness (Phase 2)Study completedNCT00071539
What this trial is testing

Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

Who this might be right for
Recurrent Glioblastoma Multiforme
Teva Branded Pharmaceutical Products R&D, Inc. 56
Next Page